Clinical Trials Logo

Postexercise Hypotension clinical trials

View clinical trials related to Postexercise Hypotension.

Filter by:
  • None
  • Page 1

NCT ID: NCT05206227 Recruiting - Clinical trials for Postexercise Hypotension

Histamine as a Molecular Transducer of Adaptation to Exercise

Start date: July 28, 2021
Phase: Early Phase 1
Study type: Interventional

This study is investigating the role of histamine in generating adaptation to exercise

NCT ID: NCT03313375 Terminated - Clinical trials for Postexercise Hypotension

Continuous vs Aerobic Postexercise Hypotension

CAPER
Start date: October 5, 2017
Phase: N/A
Study type: Interventional

This study examines the effect of obesity and gender on postexercise hypotension with three different randomized exercise protocols or varying intensity. Subjects will be separated into obese and non-obese groups and then further by gender. From there, they will be put through a control, continuous exercise bout, and aerobic interval bout of exercise in a randomized order over three visits. Post exercise blood pressure, as well as other non-invasive cardiac measures will be taken over a 4 hour period.

NCT ID: NCT03112070 Completed - Clinical trials for Postexercise Hypotension

Post-Exercise Hypotension After Water Exercise

Start date: April 4, 2016
Phase: N/A
Study type: Interventional

Hypertension is the most prevalent cardiovascular disease risk factor among individuals 60 years of age and older. Hypertension can be prevented and modified with lifestyle interventions that include regular exercise. Water exercise is widely recommended for older adults for a variety of health benefits, but few studies have assessed the immediate ambulatory blood pressure (BP) response to water exercise, a response termed postexercise hypotension (PEH). We will assess PEH after a session of water aerobics in physically active, older women with hypertension. Twenty-four women will be randomly assign to participate in a 45 min session of moderate intensity, water aerobics (WATER) and a 45 min land control session (CONTROL). All experimental sessions will start at 9 am sharply with 7 days between them. Subjects will left the experiments wearing an ambulatory BP monitor for the next 21 hr.